Vericel (VCEL) EBITDA Margin (2011 - 2026)
Vericel's EBITDA Margin was 5.23% in Q2 2026, up 3.97 percentage points from 1.26% a year earlier and up 12.24 percentage points from the prior quarter.
Powered by 
Analysis
Vericel (VCEL) EBITDA Margin (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vericel's EBITDA Margin was 10.17% through Jun 30, 2026, up 6.35 percentage points year-over-year; for FY2025, it came in at 8.18%, up 3.95 percentage points from FY2024.
- EBITDA Margin has now increased for three consecutive years, with a five-year change of +4.33 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 4.23% in FY2024 (+5.15 pp), -0.93% in FY2023 (+7.03 pp), -7.96% in FY2022 (-4.83 pp) and -3.13% in FY2021 (-6.97 pp).
- Quarterly EBITDA Margin has moved between -21.55% (Q2 2022) and 27.45% (Q4 2025) over five years.
- Compared with a year earlier, EBITDA Margin has increased for five straight quarters, with an average year-over-year change of +4.91 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was Q1 2026 (a gain of 12.20 percentage points); the worst was Q3 2021 (a drop of 25.02 percentage points).
- Per Business Quant data, VCEL's EBITDA Margin in the three quarters before Q2 2026 was -7.01% (Q1 2026), 27.45% (Q4 2025) and 9.47% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Vericel | 2.08 Bn | 1.50 Bn | 56.40 Mn | 5.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.23% |
| Mar 31, 2026 | -7.01% |
| Dec 31, 2025 | 27.45% |
| Sep 30, 2025 | 9.47% |
| Jun 30, 2025 | 1.26% |
| Mar 31, 2025 | -19.21% |
| Dec 31, 2024 | 26.48% |
| Sep 30, 2024 | -1.97% |
| Jun 30, 2024 | -8.94% |
| Mar 31, 2024 | -7.97% |
| Dec 31, 2023 | 21.36% |
| Sep 30, 2023 | -8.56% |
| Jun 30, 2023 | -10.43% |
| Mar 31, 2023 | -17.11% |
| Dec 31, 2022 | 13.52% |
| Sep 30, 2022 | -15.01% |
| Jun 30, 2022 | -21.55% |
| Mar 31, 2022 | -17.74% |
| Dec 31, 2021 | 10.31% |
| Sep 30, 2021 | -12.35% |
API Access
Vericel EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VCEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "VCEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VCEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();